Stephen Farrell

As a distinguished market leader in the healthcare staffing industry with 28 office locations within the United States, servicing healthcare facilities in all 50 states, Accountable Healthcare Staffing offers a challenging and supportive working environment, and strives to develop employees who can achieve their full potential. We operate in an atmosphere of excellence, integrity, respect and trust. We foster a culture of teamwork, inclusion and diversity in everything we pursue. Our values define who we are, underscore our commitment to clients and our healthcare professionals, and provide direction for everything we do. We offer a competitive salary and benefits package. Accountable Healthcare Staffing is committed to developing and maintaining a diverse workforce, and strongly believes in equal opportunity extended to all individuals in all aspects of the employment relationship. Please visit www.ahcstaff.com for additional information on the Company and its commitment to equal opportunity. Accountable Healthcare Staffing is a subsidiary of Mitsui & Co., Ltd. (“Mitsui”). Mitsui is one of the most diversified and comprehensive trading, investment and service enterprises in the world, with 139 offices in 66 countries as of May, 2017. Mitsui is actively taking on challenges for global business innovation around the world. For more information on Mitsui, visit www.mitsui.com.

Now a part of Mallinckrodt Pharmaceuticals Mallinckrodt Pharmaceuticals is pleased to bring Questcor and its entire business into our company. The former Questcor organization will be known as the Autoimmune and Rare Diseases business within Mallinckrodt’s Specialty Pharmaceuticals segment. We will continue their focus on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders, primarily in the fields of neurology, nephrology, rheumatology and pulmonology, areas of medicine which have significant unmet medical needs. A market-leader in specialty pharmaceuticals and medical imaging, Mallinckrodt develops, manufactures and markets products that diagnose serious illnesses and treat pain. Our pharmaceuticals business encompasses branded and generic products as well as the Active Pharmaceuticals Ingredients used to make prescription drugs. Our imaging business focuses on contrast media and delivery systems plus nuclear medicine. Together we will work tirelessly to find more imaginative ways to help more patients, accelerate product development and deliver long-term, above-market growth. Corporate Culture It’s an exciting time to be at Mallinckrodt. Our culture is defined by five hallmarks: high-performing, competitive, collaborative, engaged and trustworthy. There’s a strong sense of purpose, too, as we’re all totally focused on helping patients, whether we’re producing quality products, engaged in customer service or educating healthcare professionals. Our culture encourages collaboration, breakthrough thinking and ownership of meaningful work. We’ll empower you to act in the best interests of our customers and our company. The more you’re alert to opportunities, inspired to take the initiative and ready to make thoughtful decisions, the more successful you will be. Combine your competitive zeal with the passion to improve lives, and you’ll soon find yourself building your career as well as our business.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.

As a distinguished market leader in the healthcare staffing industry with 28 office locations within the United States, servicing healthcare facilities in all 50 states, Accountable Healthcare Staffing offers a challenging and supportive working environment, and strives to develop employees who can achieve their full potential. We operate in an atmosphere of excellence, integrity, respect and trust. We foster a culture of teamwork, inclusion and diversity in everything we pursue. Our values define who we are, underscore our commitment to clients and our healthcare professionals, and provide direction for everything we do. We offer a competitive salary and benefits package. Accountable Healthcare Staffing is committed to developing and maintaining a diverse workforce, and strongly believes in equal opportunity extended to all individuals in all aspects of the employment relationship. Please visit www.ahcstaff.com for additional information on the Company and its commitment to equal opportunity. Accountable Healthcare Staffing is a subsidiary of Mitsui & Co., Ltd. (“Mitsui”). Mitsui is one of the most diversified and comprehensive trading, investment and service enterprises in the world, with 139 offices in 66 countries as of May, 2017. Mitsui is actively taking on challenges for global business innovation around the world. For more information on Mitsui, visit www.mitsui.com.

Now a part of Mallinckrodt Pharmaceuticals Mallinckrodt Pharmaceuticals is pleased to bring Questcor and its entire business into our company. The former Questcor organization will be known as the Autoimmune and Rare Diseases business within Mallinckrodt’s Specialty Pharmaceuticals segment. We will continue their focus on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders, primarily in the fields of neurology, nephrology, rheumatology and pulmonology, areas of medicine which have significant unmet medical needs. A market-leader in specialty pharmaceuticals and medical imaging, Mallinckrodt develops, manufactures and markets products that diagnose serious illnesses and treat pain. Our pharmaceuticals business encompasses branded and generic products as well as the Active Pharmaceuticals Ingredients used to make prescription drugs. Our imaging business focuses on contrast media and delivery systems plus nuclear medicine. Together we will work tirelessly to find more imaginative ways to help more patients, accelerate product development and deliver long-term, above-market growth. Corporate Culture It’s an exciting time to be at Mallinckrodt. Our culture is defined by five hallmarks: high-performing, competitive, collaborative, engaged and trustworthy. There’s a strong sense of purpose, too, as we’re all totally focused on helping patients, whether we’re producing quality products, engaged in customer service or educating healthcare professionals. Our culture encourages collaboration, breakthrough thinking and ownership of meaningful work. We’ll empower you to act in the best interests of our customers and our company. The more you’re alert to opportunities, inspired to take the initiative and ready to make thoughtful decisions, the more successful you will be. Combine your competitive zeal with the passion to improve lives, and you’ll soon find yourself building your career as well as our business.